BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6990505)

  • 1. Effects of prostaglandins, thromboxanes, and inhibitors of their synthesis on renal and gastrointestinal function in the newborn period.
    Friedman WF; Fitzpatrick KM
    Semin Perinatol; 1980 Apr; 4(2):143-56. PubMed ID: 6990505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockers of prostaglandin synthesis: a novel therapy in the management of the premature human infant with patent ductus arteriosus.
    Friedman WF; Printz MP; Kirkpatrick SE
    Adv Prostaglandin Thromboxane Res; 1978; 4():373-81. PubMed ID: 565580
    [No Abstract]   [Full Text] [Related]  

  • 3. Recovery of prostaglandin production associated with reopening of the ductus arteriosus after indomethacin treatment in preterm infants with respiratory distress syndrome.
    Seyberth HW; Müller H; Wille L; Plückthun H; Wolf D; Ulmer HE
    Pediatr Pharmacol (New York); 1982; 2(2):127-41. PubMed ID: 12760405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of adverse renal reactions to prolonged indomethacin therapy in preterm infants with persistent ductus arteriosus.
    Seyberth HW; Rascher W; Wille L; Hackenthal E; Ulmer HE
    Pediatr Pharmacol (New York); 1983; 3(3-4):259-66. PubMed ID: 6377215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrotizing enterocolitis and gastrointestinal complications after indomethacin therapy and surgical ligation in premature infants with patent ductus arteriosus.
    O'Donovan DJ; Baetiong A; Adams K; Chen A; Smith EO; Adams JM; Weisman LE
    J Perinatol; 2003 Jun; 23(4):286-90. PubMed ID: 12774134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of prostaglandin and prostacyclin synthesis in the clinical management of patent ductus arteriosus.
    Friedman WF; Kurlinski J; Jacob J; DiSessa TG; Gluck L; Merritt TA; Feldman BH
    Semin Perinatol; 1980 Apr; 4(2):125-33. PubMed ID: 6990503
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of prostaglandins, prostacyclin, and thromboxanes in the control of prenatal patency and postnatal closure of the ductus arteriosus.
    Coceani F; Olley PM
    Semin Perinatol; 1980 Apr; 4(2):109-13. PubMed ID: 6990501
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indomethacin for closure of persisting ductus arteriosus in the premature infant].
    Linderkamp O; Versmold HT
    Monatsschr Kinderheilkd; 1981 Feb; 129(2):118-20. PubMed ID: 6112670
    [No Abstract]   [Full Text] [Related]  

  • 10. [The significance of renal prostaglandins for kidney function in early childhood].
    Seyberth HW
    Monatsschr Kinderheilkd; 1987 Apr; 135(4):178-84. PubMed ID: 3600669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.
    Hammerman C
    Clin Perinatol; 1995 Jun; 22(2):457-79. PubMed ID: 7671547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins: physiological and clinical correlations.
    Friedman WF; Molony DA; Kirkpatrick SE
    Adv Pediatr; 1978; 25():151-204. PubMed ID: 369336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
    Leonhardt A; Strehl R; Barth H; Seyberth HW
    Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacologic closure of the patent ductus arteriosus.
    Van Overmeire B; Chemtob S
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):177-84. PubMed ID: 15701582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibuprofen lysine for the prevention and treatment of patent ductus arteriosus.
    Pai VB; Sakadjian A; Puthoff TD
    Pharmacotherapy; 2008 Sep; 28(9):1162-82. PubMed ID: 18752387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fetal ductus arteriosus, a review.
    Brezinka C; Gittenberger-de Groot AC; Wladimiroff JW
    Zentralbl Gynakol; 1993; 115(10):423-32. PubMed ID: 8273432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of indomethacin in the premature infant.
    Bianchetti G; Monin P; Marchal F; Dubruc C; Boutroy MJ; Morselli PL; Vert P
    Dev Pharmacol Ther; 1980; 1(2-3):111-24. PubMed ID: 6927544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.